Protagenic Therapeutics, Inc.new (PTIX)
OTC: PTIX · CIK 0001022899 · United States
Every official Protagenic Therapeutics, Inc.new filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open PTIX filings
Protagenic Therapeutics, Inc.new documents
- Protagenic Therapeutics, Inc.new 10-K 2026PTIX 10-K 2026: annual report for fiscal 2026
- Protagenic Therapeutics, Inc.new 10-K 2025PTIX 10-K 2025: annual report for fiscal 2025
- Protagenic Therapeutics, Inc.new 10-K 2024PTIX 10-K 2024: annual report for fiscal 2024
- Protagenic Therapeutics, Inc.new 10-K 2023PTIX 10-K 2023: annual report for fiscal 2023
- Protagenic Therapeutics, Inc.new 10-K 2022PTIX 10-K 2022: annual report for fiscal 2022
- Protagenic Therapeutics, Inc.new 10-Q 2026PTIX 10-Q 2026: quarterly report for fiscal 2026
- Protagenic Therapeutics, Inc.new 10-Q 2025PTIX 10-Q 2025: quarterly report for fiscal 2025
- Protagenic Therapeutics, Inc.new 10-Q 2024PTIX 10-Q 2024: quarterly report for fiscal 2024
- Protagenic Therapeutics, Inc.new 10-Q 2023PTIX 10-Q 2023: quarterly report for fiscal 2023
- Protagenic Therapeutics, Inc.new 10-Q 2022PTIX 10-Q 2022: quarterly report for fiscal 2022
- Protagenic Therapeutics, Inc.new 8-K 2026PTIX 8-K 2026: current report for fiscal 2026
- Protagenic Therapeutics, Inc.new 8-K 2025PTIX 8-K 2025: current report for fiscal 2025
- Protagenic Therapeutics, Inc.new 8-K 2024PTIX 8-K 2024: current report for fiscal 2024
- Protagenic Therapeutics, Inc.new 8-K 2023PTIX 8-K 2023: current report for fiscal 2023
- Protagenic Therapeutics, Inc.new 8-K 2022PTIX 8-K 2022: current report for fiscal 2022
- Protagenic Therapeutics, Inc.new DEF 14A 2026PTIX DEF 14A 2026: proxy statement for fiscal 2026
- Protagenic Therapeutics, Inc.new DEF 14A 2025PTIX DEF 14A 2025: proxy statement for fiscal 2025
- Protagenic Therapeutics, Inc.new DEF 14A 2024PTIX DEF 14A 2024: proxy statement for fiscal 2024
- Protagenic Therapeutics, Inc.new DEF 14A 2023PTIX DEF 14A 2023: proxy statement for fiscal 2023
- Protagenic Therapeutics, Inc.new DEF 14A 2022PTIX DEF 14A 2022: proxy statement for fiscal 2022
- Protagenic Therapeutics, Inc.new Form 4 2026PTIX Form 4 2026: insider trading filing for fiscal 2026
- Protagenic Therapeutics, Inc.new Form 4 2025PTIX Form 4 2025: insider trading filing for fiscal 2025
- Protagenic Therapeutics, Inc.new Form 4 2024PTIX Form 4 2024: insider trading filing for fiscal 2024
- Protagenic Therapeutics, Inc.new Form 4 2023PTIX Form 4 2023: insider trading filing for fiscal 2023
- Protagenic Therapeutics, Inc.new Form 4 2022PTIX Form 4 2022: insider trading filing for fiscal 2022
- Protagenic Therapeutics, Inc.new S-1 2026PTIX S-1 2026: registration statement for fiscal 2026
- Protagenic Therapeutics, Inc.new S-1 2025PTIX S-1 2025: registration statement for fiscal 2025
- Protagenic Therapeutics, Inc.new S-1 2024PTIX S-1 2024: registration statement for fiscal 2024
- Protagenic Therapeutics, Inc.new S-1 2023PTIX S-1 2023: registration statement for fiscal 2023
- Protagenic Therapeutics, Inc.new S-1 2022PTIX S-1 2022: registration statement for fiscal 2022
- Protagenic Therapeutics, Inc.new 13F 2026PTIX 13F 2026: institutional holdings for fiscal 2026
- Protagenic Therapeutics, Inc.new 13F 2025PTIX 13F 2025: institutional holdings for fiscal 2025
- Protagenic Therapeutics, Inc.new 13F 2024PTIX 13F 2024: institutional holdings for fiscal 2024
- Protagenic Therapeutics, Inc.new 13F 2023PTIX 13F 2023: institutional holdings for fiscal 2023
- Protagenic Therapeutics, Inc.new 13F 2022PTIX 13F 2022: institutional holdings for fiscal 2022
More companies